Field Medical Closes Oversubscribed $35 Million Series B to Advance Development of FieldForce™ Pulsed Field Ablation Platform

The Series B financing will support the initiation of the company’s pivotal VERITAS trial, advance the FieldForce Ablation System development, and further expand Field Medical’s clinical and regulatory capabilities.